Stoke Therapeutics Inc (NAS:STOK)
$ 13.05 -0.05 (-0.38%) Market Cap: 690.88 Mil Enterprise Value: 409.98 Mil PE Ratio: 0 PB Ratio: 2.81 GF Score: 40/100

Stoke Therapeutics Inc Extraordinary Shareholders Meeting Transcript

Oct 24, 2023 / 01:00PM GMT
Release Date Price: $3.57 (-1.38%)
Edward Kaye
Stoke Therapeutics Inc - CEO & Director

Good morning, ladies and gentlemen. I am Edward Kaye, Chief Executive Officer of Stoke Therapeutics. It is a pleasure to welcome you to our special meeting of stockholders. Thank you for joining us today.

We're excited to be hosting our special meeting virtually as this format allows us to be more inclusive and reach a greater number of our stockholders. We have stockholders attending via the web portal and the 800 number that we have provided. We will conduct the formal business portion of our meeting and report the preliminary results of our voting. We will then adjourn the formal business of the special meeting and hold a question and answer session.

It is now 9:00 Eastern Time on October 24, 2023, and this meeting is officially called to order. I would also like to introduce our corporate officers who are with us this morning -- Stephen Tulipano, our Chief Financial Officer, and Jonathan Allan, our General Counsel and Corporate Secretary. I will serve as Chair of this meeting.

I also wanted to introduce Julia Forbess

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot